Related Articles
In vivo studies of the anti-tumor effects of a human prolactin antagonist, hPRL-G129R
In vitro studies of a prolactin antagonist, hPRL-G129R in human breast cancer cells.
Autocrine human growth hormone reduces mammary and endometrial carcinoma cell sensitivity to mitomycin C
The role of human prolactin and its antagonist, G129R, in mammary gland development and DMBA-initiated tumorigenesis in transgenic mice
IMMUNOHISTOCHEMICAL CHARACTERISTICS OF BREAST-CARCINOMA IN PATIENTS RECEIVING NEUROLEPTIC THERAPY